JPML to Hear Oral Arguments on Belviq Lawsuit Consolidation in July

A panel of federal judges has agreed to hear oral arguments next month over whether all Belviq cancer lawsuits should be consolidated before one judge, for coordinated discovery and pretrial proceedings.

Although Belviq (lorcaserin) was just introduced as a new prescription weight loss drug in 2012, the medication was recalled from the market last year, after post marketing data found a large number of reports involving users diagnosed with cancer.

A Belviq recall was announced in February 2020, after federal health officials concluded that any benefits provided by the weight loss drug cannot justify the potential risk, and at least 13 product liability lawsuits have already been filed by former users diagnosed with various types of cancer.

Learn More About

Belviq Lawsuits

Side effects of Belviq may increase the risk of cancer, resulting in a diet drug recall and lawsuits.

Learn More About this Lawsuit See If You Qualify For Compensation

The size of the litigation is expected to continue to grow over the coming months and years, as Belviq injury lawyers continue to review potential claims, with some estimates suggesting that several hundred lawsuits may eventually be filed throughout the federal court system, each raising similar allegations that former users may have avoided cancer if the makers of the diet drug had properly researched the potential side effects.

To help coordinate and manage the growing litigation, a group of plaintiffs joined together to file a motion to transfer with the U.S. Judicial Panel on Multidistrict Litigation (JPML) in April, asking that cases pending nationwide be centralized in the Eastern District of Louisiana for discovery and pretrial proceedings.

Eisai Inc. and Arena Pharmaceuticals, who are named as defendants in the litigation, have opposed the request to consolidate the Belviq cases, arguing that establishing a class action-like multidistrict litigation (MDL) should be a move of last resort.

On June 16, the JPML issued a Notice of Hearing Session (PDF), scheduling oral arguments on the motion for July 29, at the John Joseph Moakley United States Courthouse in Boston, Massachusetts. The notice indicates the panel will hear the oral arguments by videoconference or teleconference, due to the ongoing COVID-19 pandemic and the recommended safety precautions.

If a Belviq MDL is established, cases filed in U.S. District Courts nationwide will be transferred to one court for management, and series of early “bellwether” trials designed to help gauge how juries are likely to respond to certain evidence that will be repeated throughout the litigation. However, if Belviq cancer settlements or another resolution is not reached following the MDL proceedings, each individual Belviq case may later be returned to the U.S. District Court where it was originally filed for a separate trial in the future.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted today)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.

Lawyers Propose Direct Filing of Toxic Baby Food Lawsuits Over Autism, ADHD in Federal MDL
Lawyers Propose Direct Filing of Toxic Baby Food Lawsuits Over Autism, ADHD in Federal MDL (Posted today)

A federal judge has been asked to allow direct filing of future baby food lawsuits over autism and ADHD side effects with the MDL court, but the parties disagree over whether that order should allow multi-plaintiff complaints.

Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General
Social Media Mental Health Warnings Should Be Required To Protect Teens: U.S. Surgeon General (Posted 2 days ago)

U.S. Surgeon General says social media platforms like Facebook, Instagram and Tiktok should carry label warnings, alerting parents that youth who use the platforms face an increased risk of mental health side effects.